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Abstract
Peptic ulcer disease is the most common cause of upper gastrointestinal (GI) bleeding. In most of the cases, bleeding from a
peptic ulcer stops spontaneously. Arterial diameters in bleeding ulcers can measure up to 3.45 mm, but in most cases the
diameter of the bleeding artery is small (o2 mm). High-dose intravenous proton pump inhibitors after endoscopic therapy
for a bleeding ulcer reduce recurrent bleeding risk and surgery. The endoscopic appearance of an ulcer provides important
prognostic information. Clean based ulcers and ulcers with a ﬂat pigmented spot have low rebleeding risks. Major stigmata
of hemorrhage (an adherent clot, a visible vessel, or active bleeding) are associated with high rebleeding risks. Endoscopic
treatment in patients with high-risk stigmata results in improved outcomes. Common endoscopic techniques and the
devices used to treat upper GI ulcer bleeding, including injection therapy, thermal coagulation, endoclip application, and
hemostatic powder spray are described in the given video. Different clinical scenarios are presented. This article is part of an
expert video encyclopedia.
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Materials
• Endoscopes: Olympus GIF-Q180; Tokyo, Japan.
• Epinephrine.
• Injection needle: Carr-Lockes Injection Needle; US
Endoscopy, Mentor, OH, USA.
• Generator:
J ERBE, Marietta, GA, USA.
J ConMed, Chelmsford, MA, USA.
• Bipolar probes:
J Solars Probe; Olympus America, Center Valley, PA,
USA.
J Gold Probes; Boston Scientiﬁc, Boston, MA, USA.
• Through-the-Scope Clipping Devices: Instincts Clip; Cook
Medical, Winston-Salem, NC, USA.
• Over-the-Scope Clipping (OTSC) Device: OTSCs; Ovesco
Endoscopy AG, Germany.
• Hemostatic powder spray: Hemosprays; Cook Medical,
Winston-Salem, NC, USA.
Background and Endoscopic Procedure
Peptic ulcers are the most common cause of upper gastro-
intestinal (GI) bleeding. In most of the cases, bleeding from a
peptic ulcer stops spontaneously. Arterial diameters in bleed-
ing ulcers can measure up to 3.45 mm, but in most cases the
diameter of the bleeding artery is small (o2 mm). High-dose
intravenous proton pump inhibitors after endoscopic therapy
for a bleeding ulcer reduce recurrent bleeding risk and surgery.
The endoscopic appearance of an ulcer provides important
prognostic information. Clean-based ulcers and ulcers with a
ﬂat pigmented spot have low rebleeding risks. Prospective
randomized trials have demonstrated that endoscopic treat-
ment in patients with major bleeding stigmata results in a
signiﬁcant reduction in further bleeding, blood transfusions,
the length of hospital stay, and the need for urgent surgery.
Appearance of the Ulcer and Major Stigmata of Bleeding
Endoscopic intervention is indicated in active bleeding, non-
bleeding visible vessels, and active bleeding or visible vessels
exposed after adherent clot removal. For actively bleeding
ulcers, many experts advocate preinjection with 1 ml of
1:10 000 epinephrine in four quadrants to achieve temporary
hemostasis and better visualization. If an adherent clot is seen,
direct endoscopic suction and clot removal with a snare or
biopsy forceps should be attempted to remove the adherent
clot. Before clot removal and at the discretion of the en-
doscopist, the base of the adherent clot may be preinjected
with 1 ml of 1:10 000 epinephrine in four quadrants. Once
the clot is removed, any major stigmata of bleeding in the
ulcer base must be ruled out.
Devices and Procedural Techniques
There are four commonly used endoscopic techniques in
treating a bleeding ulcer: injection therapy; thermal coagu-
lation; endoscopic clipping; and, most recently, hemostatic
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powders that are sprayed onto the bleeding ulcer. Injection
therapy is commonly used for temporary hemostasis and
improved visualization during signiﬁcant active bleeding.
The option to preinject is at the discretion of the endoscopist
and often reﬂects personal preference. If visualization is opti-
mal, including a clear view of the targeted vessel, a deﬁnitive
intervention, such as clipping without preinjection may
be used. During injection therapy, a variety of solutions,
including epinephrine (1:10 000) and even normal saline,
may be injected into the ulcer base in four quadrants using a
catheter equipped with a retractable needle. Injection therapy
delivers temporary local temponade and vasoconstriction.
Injection therapy is usually utilized in combination with other
more deﬁnitive techniques, such as thermal coagulation or
clipping.
Thermal coagulation is another commonly used endo-
scopic technique to treat bleeding ulcers; it relies on thermal
contact to achieve local temponade and coaptive coagulation
of the underlying vessel. Bipolar and heater probes are pre-
ferred devices. Some bipolar probes incorporate an injection
needle. The maximal temperature generated by the heater
probe is 250 1C, whereas maximal temperature generated with
the bipolar probe is 100 1C. In animal studies, both bipolar
and heater probes are highly effective in achieving hemostasis
and coagulating mesenteric arteries up to 2 mm in diameter.
For a visible vessel and an active bleeding ulcer, many experts
recommend using a 10-F bipolar or heater probe for therapy.
However, a 10-F endoscopic device requires a therapeutic
gastroscope. In the author’s experience, coagulation with a 7-F
probe is as effective as with a 10-F probe. Endotherapy using a
7-F probe is a more ﬂexible option when the ulcer is located at
the gastric cardia, lesser curvature, and in the duodenal bulb.
During bipolar electrocoagulation and heater probe therapy,
the probe is placed ﬁrmly on the bleeding lesion until cavi-
tation or a ‘footprint’ is obtained. The energy output of the
heat probe should be set at 30 J, and a minimal three coaptive
pulses are applied. For bipolar thermal coagulation, the energy
output should be set at 20 W with the probe ﬁrmly applied on
the vessel for 8–10 s. For both probes, coagulation using the
side or tip of the probe probably achieves the same therapeutic
effect.
Increasingly, through-the-scope (TTS) endoclips are
being used to ligate bleeding vessels. Studies have shown
that endoclip application is equally effective in achieving
hemostasis when compared to thermal coagulation. The
advantages of using TTS endoclips include no special setup,
expedient application, nonthermal application, and the ability
to approximate ulcer or defect margins as well as to achieve
hemostasis. Endoclips are particularly useful in treating
rebleeding ulcers and continuously bleeding ulcers when ad-
equate treatment with thermal coagulation fails. The down-
side is the increased cost associated with disposable clip
devices. Earlier studies showed that older versions of the
endoclip are less effective in achieving hemostasis if the
bleeding artery is greater than 2 mm. Therefore, Food and
Drug Administration-recommended endoclip application is
restricted to vessels less than 2 mm in diameter. Newly avail-
able endoclips accommodate up to a 16-mm opening span,
can be reopened and repositioned repeatedly, and are easily
rotatable. Unlike older versions, Instincts clips; Cook
Medical, Winston-Salem, NC, USA are approved for magnetic
resonance imaging (MRI) with ﬁeld strengths up to 3 T. Early
reports suggest that medium-sized arteries greater than
2–3 mm in diameter can be successfully ligated with the newer
generation clipping devices. With these newer generation
endoclips, en face or tangential application is equally effective.
To maximize the amount of target tissue captured inside the
endoclip during clip closure, suction is recommended with
opened clip arms gently pressed over the target tissue imme-
diately before clip deployment. Although a single endoclip
may achieve hemostasis on a vessel, two clips are usually ap-
plied on a major bleeding stigmata, aiming to ligate the
feeding vessel. Endoclip application can be used to guide
angiographic embolization if needed.
Recently, hemostatic powder sprays and OTSC devices have
been tested to treat ulcer bleeding, with promising results. A
proprietary hemostatic powder (Hemosprays; Cook Medical,
Winston-Salem, NC, USA) has been proven to be effective in
high-pressure bleeding from external wounds, in a survival GI
bleeding animal model, and in achieving hemostasis in ma-
lignant bleeding. The OTS clip (OTSCs; Ovesco Endoscopy
AG, Germany) provides an additional advantage of approxi-
mating large defects. More clinical data are needed before the
OTS clipping devices and hemostatic powders could be rec-
ommended for widespread use. Meanwhile, thermal coagu-
lation, TTS endoclip application, and injection therapy are the
mainstream therapeutic modalities for treating ulcer bleeding
in the upper GI tract.
Recurrent Bleeding Risks and Complications
Major complications associated with endoscopic therapy are
rare. Despite endoscopic therapy, independent risk factors
associated with rebleeding include large ulcer size (42 cm),
active bleeding, posterior duodenal ulcer, lesser gastric curve
ulcer, and hemodynamic instability. Relative inaccessibility,
suboptimal visualization, and probable larger artery size as-
sociated with ulcers at the posterior bulb and lesser gastric
curvature probably explain the high rebleeding and failure
rates. Repeated treatment can be attempted in patients
with recurrent bleeding, and permanent hemostasis can be
achieved in approximately half these cases. Just more than
10% of patients require urgent angiographic embolization or
surgery for bleeding despite endoscopic therapy. Routine sec-
ond-look endoscopy does not change clinical outcomes and is
not recommended.
Key Learning Points/Tips and Tricks
• Peptic ulcers are the most common cause of upper GI
bleeding.
• In most of the cases, bleeding from a peptic ulcer stops
spontaneously.
• High-dose intravenous proton pump inhibitors after
endoscopic therapy for a bleeding ulcer reduce recurrent
bleeding risk and surgery.
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• The endoscopic appearance of an ulcer provides important
prognostic information and helps to guide endoscopic
intervention.
Endoscopic
appearance
of the ulcer
Rebleeding
risk
Endotherapy Endoscopic
intervention
Active
bleeding
High Yes Deﬁnitive
therapy7injection
therapy
Nonbleeding
visible
vessel
High Yes Deﬁnitive
therapy7injection
therapy
Adherent
clot
Medium Yes Remove the clot
and treat bleeding
or visible vessel
exposed after clot
removal
Flat
pigmented
spot
Low No
Clean based Low No
Deﬁnitive endoscopic interventions include thermal co-
agulation, endoclip application, and/or combination therapy.
The option to preinject is at the discretion of the en-
doscopist and often reﬂects personal preference. If visual-
ization is optimal, including a clear view of the targeted vessel,
a deﬁnitive intervention, such as clipping without preinjection
may be used.
• Endoscopic techniques in treating a bleeding ulcer are the
following:
J Injection therapy.
J Delivers temporary local temponade and
vasoconstriction.
• Improved visualization during signiﬁcant active
bleeding.
J Thermal coagulation.
• Bipolar and heater probes are preferred devices.
• Provides local temponade and coaptive coagulation
of the underlying vessel.
• During thermal application, the probe is placed
ﬁrmly on the bleeding lesion until cavitation or a
‘footprint’ is obtained.
J Endoscopic clipping with TTS and OTS clips.
• Endoclip application is equally effective in achieving
hemostasis when compared to thermal coagulation.
• Particularly useful in treating rebleeding ulcers and
when thermal coagulation fails.
• Newer generations of TTS endoclips offer long
opening span, ratability, ability to reopen and re-
position repeatedly, and MRI compatibility.
• Endoscopic suction is recommended with opened
TTS clip arms gently pressed over the target tissue
immediately before clip deployment.
• Endoclip application can be used to guide angio-
graphic embolization if needed.
• The OTS clip provides an additional advantage of
approximating large defects.
J Hemostatic powder spray.
• Effective in achieving hemostasis in high-pressure
bleeding from external wounds, in a survival GI
bleeding animal model, and in malignant bleeding.
• Independent risk factors associated with rebleeding include
‘LALPH’:
J Large ulcer size (42 cm).
J Active bleeding.
J Lesser gastric curve ulcer.
J Posterior duodenal ulcer.
J Hemodynamic instability.
• Repeated treatment can be attempted in patients with
recurrent bleeding with approximately 50% success rate.
• Routine second-look endoscopy does not change clinical
outcomes and is not recommended.
Complications and Risk Factors
Primary failure in achieving hemostasis, rebleeding risk, and
perforation.
Alternatives
Conservative management, proton pump inhibitors, angio-
graphic embolization, and surgery.
Scripted Voiceover
Time (min:sec) Voiceover text
00:01 Peptic ulcers are the most common cause of upper
Gastrointestinal (GI) bleeding.
00:07 In most cases, the arterial diameters in bleeding
ulcers measure less than 2 mm, but can be up to
3.45 mm.
00:19 The endoscopic appearance of an ulcer provides
important prognostic information.
00:28 Endoscopic intervention is indicated in active
bleeding, non-bleeding visible vessel, and active
bleeding or visible vessel exposed after adherent
clot removal.
00:44 This is a clean based gastric ulcer.
00:50 In general, ﬂat pigmented spots are better
visualized under digital chromoendoscopy such
as narrow band imaging (NBI).
01:07 Within this posterior bulb ulcer, a ﬂat pigmented
spot can be seen.
01:25 In this patient, a large ulceration with an adherent
clot can be seen at the gastric angularis.
01:35 Direct endoscopic suction, clot removal with a
snare or biopsy forceps should be attempted to
remove the adherent clot.
01:48 Once the clot is removed, any major stigmata of
bleeding in the ulcer base must be ruled out.
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01:58 A visible vessel is seen within the ulcer base.
02:08 For actively bleeding ulcers, many experts advocate
pre-injection in four quadrants to achieve
temporary hemostasis and better visualization.
02:22 Injection therapy delivers temporary local
tamponade and vasoconstriction.
02:34 Some bipolar probes incorporate an injection
needle.
02:43 During thermal coagulation, the bipolar or heater
probe is placed ﬁrmly on the bleeding lesion to
achieve local tamponade and coaptive
coagulation of the underlying vessel.
03:01 A visible vessel is seen within the duodenal
ulceration.
03:09 Thermal coagulation using a bipolar probe is used
to achieve coaptive coagulation.
03:19 The probe is placed ﬁrmly on the vessel until
cavitation or a "foot print" is obtained.
03:30 For bipolar thermal coagulation, the energy output
should be set at 20–25 W with the probe ﬁrmly
applied on the vessel for several seconds.
03:44 The tip of the probe is ﬂushed with water after each
thermal application.
03:54 In the settings of a visible vessel or an adherent
clot, the option to pre-inject is at the discretion of
the endoscopist and often reﬂects personal
preference.
04:12 In our experience, coagulation with a 7 F probe is
as effective as with a 10 F probe.
04:23 Endotherapy using a 7 F probe is a more ﬂexible
option when the ulcer is located at the gastric
cardia, lesser curvature, and in the duodenal
bulb.
04:40 For both bipolar and heater probes, coagulation
using the side or tip of the probe probably
achieves the same therapeutic effect.
04:59 Several cycles of treatment can be performed until
cavitation or a "foot print" is obtained.
05:16 Increasingly, through-the-scope (TTS) endoclips
are being used to ligate bleeding vessels.
05:25 Studies have shown that endoclip application is
equally effective in achieving hemostasis when
compared to thermal coagulation.
05:38 Newly available endoclips accommodate up to a
16 mm opening span, can be reopened and
repositioned repeatedly, and are easily
rotatable.
05:54 Unlike older versions, Instincts clips are approved
for MRI with ﬁeld strengths up to 3 T.
06:06 The advantages of using endoclips include no
special setup, expedient application, non-thermal
application, and the ability to approximate ulcer
or defect margins as well as to achieve
hemostasis.
06:25 Some versions of the endoclips have excellent
rotational ability.
06:43 A visible vessel can be seen in this antral ulcer.
06:50 Endoclip application provides the ability to
approximate the ulcer or defect margins as well
as to achieve hemostasis.
07:03 With these newer generation endoclips, en face or
tangential application is equally effective.
07:16 To maximize the amount of target tissue captured
inside the endoclip during clip closure, suction is
recommended with opened clip arms gently
pressed over the target tissue immediately before
clip deployment.
07:41 This patient has an actively bleeding duodenal ulcer
with an adherent clot.
07:50 With direct endoscopic suction, the adherent clot is
removed.
08:00 Active oozing stopped spontaneously and a visible
vessel is exposed.
08:11 We proceed with endoclip application without pre-
injection.
08:26 The opened endoclip should be directed at the base
of the visible vessel.
08:35 The opened clip arms are gently pressed over the
target vessel.
08:42 Endoscopic suction is applied before clip deployment.
08:56 This patient has a bleeding duodenal ulcer without
an adherent clot.
09:03 Despite active oozing, optimal visualization of the
ulcer base can be achieved.
09:15 In this situation, the option of pre-injection is at the
discretion of the endoscopist.
09:25 In our experience, if the visualization is optimal
including a clear view of the target vessel
or ulcer base, a deﬁnitive intervention such
as clipping without pre-injection may be used.
09:45 Although a single endoclip may achieve hemostasis
on a vessel, two clips are usually applied on a
major bleeding stigmata aiming to ligate the
feeding vessel.
10:06 In this case, a visible vessel is seen within a large
and likely chronic ulceration after clot removal.
10:19 Without pre-injection, two endoclips are placed on
the visible vessel.
10:30 Newer generations of endoclips are often able to
penetrate the scar tissues associated with
chronic ulcerations.
10:45 Endoclip application can be used to guide
angiographic embolization if needed.
11:00 In approaching ulcer bleeding, over-the-scope
clipping devices can also be used.
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11:10 This video case is provided by Dr. Thomas Kratt.
11:16 The patient is receiving anti-coagulation and there
is an actively spurting antral ulceration.
11:26 Hemostasis is immediately achieved with an
over-the-scope clipping device application (i.e.,
Ovesco endoclip_.
11:45 During routine follow up endoscopy, the over-the-
scope clipping device is seen in a good position
and around the ulcer crater.
12:00 Gradual healing of this antral ulceration is
documented on follow up endoscopies.
12:22 This video case is provided by Dr. Enric Brullet.
12:30 Spurting arterial bleeding is seen from this
malignant ulceration.
12:38 Endoscopic treatment options are very limited in
this situation.
12:48 With hemostatic powder spray, hemostasis is
achieved conveniently.
13:11 Thank you for your attention.
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